The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Angiotensin-converting enzyme inhibitor prescription is associated with decreased progression-free survival (PFS) and overall survival (OS) in patients with lung cancers treated with PD-1/PD-L1 immune checkpoint blockers.
 
Soleine Medjebar
No Relationships to Disclose
 
Corentin Richard
No Relationships to Disclose
 
Jean-David Fumet
No Relationships to Disclose
 
Julie Malo
No Relationships to Disclose
 
Arielle Elkrief
No Relationships to Disclose
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Merck (Inst)
 
Mustapha Tehfe
No Relationships to Disclose
 
Marie Florescu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche Canada
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Roche
 
Romain Boidot
No Relationships to Disclose
 
Caroline Truntzer
No Relationships to Disclose
 
Bertrand Routy
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Roche
Research Funding - Amgen (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Roche; SERVIER